tiprankstipranks
Aptose Biosciences (APTOF)
OTHER OTC:APTOF
US Market
APTOF
Aptose Biosciences
RESEARCH TOOLSreports
Want to see APTOF full AI Analyst Report?

Aptose Biosciences (APTOF) Income Statement

1,271 Followers

Aptose Biosciences Income Statement

Last quarter (Q4 2025), Aptose Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Aptose Biosciences's net income was $-7.88M. See Aptose Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -425.32K$ 0.00$ -474.55K$ -507.08K$ -616.53K
Operating Expenses
$ 24.73M$ 26.26M$ 52.36M$ 42.60M$ 65.45M
Depreciation and Amortization
$ 425.32K$ 32.00K$ 88.00K$ 120.00K$ 150.00K
EBITDA
$ -24.73M$ -26.23M$ -52.27M$ -42.48M$ -65.30M
Operating Income
$ -25.16M$ -26.26M$ -52.36M$ -42.60M$ -65.45M
Other Income/Expenses
$ -758.04K$ 827.00K$ 1.15M$ 779.00K$ 93.00K
Pretax Income
$ -25.91M$ -25.43M$ -51.21M$ -41.82M$ -65.35M
Net Income
$ -25.91M$ -25.43M$ -51.21M$ -41.82M$ -65.35M
Per Share Metrics
Basic EPS
$ -10.59$ -0.04$ -7.58$ -6.80$ -11.01
Diluted EPS
$ -10.59$ -0.13$ -7.58$ -6.80$ -11.00
Weighted Average Shares Outstanding
 2.45M 698.98M 6.75M 6.15M 5.94M
Weighted Average Shares Outstanding (Diluted)
 2.45M 197.70M 6.75M 6.15M 4.56M
Currency in USD

Aptose Biosciences Earnings and Revenue History